Patents by Inventor Matthias Zehner

Matthias Zehner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075139
    Abstract: The present invention relates to a method for obtaining monoclonal human antibodies directed against an infectious pathogen, monoclonal human antibodies or binding fragments thereof which are directed against an infectious pathogen as obtained by the method of the invention, a pharmaceutical composition comprising such monoclonal human antibodies, a kit comprising such antibodies, and the monoclonal antibodies or binding fragments thereof and the pharmaceutical composition and the kit for use as a medicament and in the treatment or prevention of a disease caused by the infectious pathogen.
    Type: Application
    Filed: October 7, 2020
    Publication date: March 7, 2024
    Inventors: Florian Klein, Matthias Zehner, Stefanie Ehrhardt, Ron Diskin
  • Publication number: 20210371503
    Abstract: The present invention relates to antibodies or antigen-binding fragments thereof against SARS-related coronavirus, a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof, a kit comprising such antibodies or antigen-binding fragments thereof. The present invention also relates to the antibodies or antigen-binding fragments thereof, the pharmaceutical composition, and the kit, for use as a medicament, and in the treatment or prevention of a disease caused by SARS-related coronavirus.
    Type: Application
    Filed: May 28, 2021
    Publication date: December 2, 2021
    Inventors: Stephan Becker, Henning GrĂ¼ll, Florian Klein, Christoph Kreer, Matthias Zehner